https://www.selleckchem.com/pr....oducts/enfortumab-ve
esection. Dexamethasone failed to demonstrate any protective advantage in terms of mitigating short-term PMCs or infectious complications, or to confer any long-term survival benefit. Tumor biology, multimodality therapy, and PMCs remain the main prognostic factors after PDAC resection. Laparoscopic liver resection has been increasingly utilized due to its less invasiveness approach compared with open surgery,1 3 but often creates challenges. Hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) portends a
Like
Comment
Share
